AGENUS INC — Director's Dealing 2015

Apr 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2014-05-08

Reporting Person: Malik Shahzad (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-08	Common Stock	J	111289	$2.999	Acquired	1107377	Indirect
2015-04-28	Common Stock	S	700000	$7.1608	Disposed	407377	Indirect
2015-04-29	Common Stock	S	407377	$7.0176	Disposed	0	Indirect

Footnotes

F1: On May 8, 2014, Agenus Inc. issued to Advent Venture Partners LLP ("Advent") and its affiliated entities, and not Dr. Malik in his individual capacity, 111,289 shares of common stock of Agenus Inc., as repayment for certain indebtedness owed by 4-Antibody-AG, a wholly-owned subsidiary of Agenus Inc., to Advent and its affiliated entities as former shareholders of 4-Antibody AG prior to Agenus Inc.'s acquisition of 4-Antibody AG in February 2014. Dr. Malik is a GP of Advent Venture Partners LLP and shares voting and investment power of the shares, and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F2: Represents shares sold by Advent Venture Partners LLP and its affiliated entities, and not Dr. Malik in his individual capacity.